相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone
Laura Torrente et al.
REDOX BIOLOGY (2020)
Lenvatinib: A Review in Hepatocellular Carcinoma
Zaina T. Al-Salama et al.
DRUGS (2019)
NAD(P)H: Quinone oxidoreductase 1 overexpression in hepatocellular carcinoma potentiates apoptosis evasion through regulating stabilization of X-linked inhibitor of apoptosis protein
Wan-Yu Li et al.
CANCER LETTERS (2019)
NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance
Xiaoguang Li et al.
NATURE COMMUNICATIONS (2019)
NQO1-dependent, Tumor-selective Radiosensitization of Non-small Cell Lung Cancers
Edward A. Motea et al.
CLINICAL CANCER RESEARCH (2019)
NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma
Hong-Zhong Zhou et al.
CELL COMMUNICATION AND SIGNALING (2019)
ROS and the DNA damage response in cancer
Upadhyayula Sai Srinivas et al.
REDOX BIOLOGY (2019)
Y-90 Radioembolization Combined with a PD-1 Inhibitor for Advanced Hepatocellular Carcinoma
Eric Wehrenberg-Klee et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
ROS signalling in the biology of cancer
Jennifer N. Moloney et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
Role of ferroptosis in hepatocellular carcinoma
Jianhua Nie et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Prognostic implication of NQO1 overexpression in hepatocellular carcinoma
Lijuan Lin et al.
HUMAN PATHOLOGY (2017)
The NQO1 bioactivatable drug, -lapachone, alters the redox state of NQO1+pancreatic cancer cells, causing perturbation in central carbon metabolism
Molly A. Silvers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer
Muhammad Shaalan Beg et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers
Yang Yang et al.
SCIENTIFIC REPORTS (2017)
Induction of reactive oxygen species: an emerging approach for cancer therapy
Zhengzhi Zou et al.
APOPTOSIS (2017)
Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors
Xiumei Huang et al.
CANCER CELL (2016)
NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer
Long-Shan Li et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
Su Jong Yu
CLINICAL AND MOLECULAR HEPATOLOGY (2016)
Clinical outcomes of patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective study of routine clinical practice in multi-institutions
Sae Hwan Lee et al.
BMC CANCER (2015)
NQO1 protein expression predicts poor prognosis of non-small cell lung cancers
Zhenling Li et al.
BMC CANCER (2015)
Liver expression of Nrf2-related genes in different liver diseases
Ming-Liang Cheng et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2015)
Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone
Gaurab Chakrabarti et al.
SCIENTIFIC REPORTS (2015)
Connexin32 regulates hepatoma cell metastasis and proliferation via the p53 and Akt pathways
Bixing Zhao et al.
ONCOTARGET (2015)
Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by β-lapachone
Gaurab Chakrabarti et al.
CANCER & METABOLISM (2015)
Tumor-Selective, Futile Redox Cycle-Induced Bystander Effects Elicited by NQO1 Bioactivatable Radiosensitizing Drugs in Triple-Negative Breast Cancers
Lifen Cao et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
PARP-1 Hyperactivation and Reciprocal Elevations in Intracellular Ca2+ During ROS-Induced Nonapoptotic Cell Death
Fengjiao Zhang et al.
TOXICOLOGICAL SCIENCES (2014)
Catalase Abrogates β-Lapachone-Induced PARP1 Hyperactivation-Directed Programmed Necrosis in NQO1-Positive Breast Cancers
Erik A. Bey et al.
MOLECULAR CANCER THERAPEUTICS (2013)
An NQO1 Substrate with Potent Antitumor Activity That Selectively Kills by PARP1-Induced Programmed Necrosis
Xiumei Huang et al.
CANCER RESEARCH (2012)
Modulating Endogenous NQO1 Levels Identifies Key Regulatory Mechanisms of Action of β-Lapachone for Pancreatic Cancer Therapy
Long Shan Li et al.
CLINICAL CANCER RESEARCH (2011)
Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders
David M. Goldstein et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Prostate Cancer Radiosensitization through Poly(ADP-Ribose) Polymerase-1 Hyperactivation
Ying Dong et al.
CANCER RESEARCH (2010)
An NQO1-and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone
Erik A. Bey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD(+) into a nuclear signal
MY Kim et al.
GENES & DEVELOPMENT (2005)
Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues
D Sieger et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
NAD(P)H:quinone oxidoreductase activity is the principal determinant of β-lapachone cytotoxicity
JJ Pink et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission
AA Pieper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
